These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12086977

  • 1. Elevated mean arterial pressure in the ovariectomized rat was normalized by ET(A) receptor antagonist therapy: absence of cardiac hypertrophy and fibrosis.
    Mercier I, Pham-Dang M, Clement R, Gosselin H, Colombo F, Rouleau JL, Calderone A.
    Br J Pharmacol; 2002 Jul; 136(5):685-92. PubMed ID: 12086977
    [Abstract] [Full Text] [Related]

  • 2. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy.
    Wolf SC, Amend T, Risler T, Amann K, Brehm BR.
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():276S-279S. PubMed ID: 12193103
    [Abstract] [Full Text] [Related]

  • 3. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S, Long CL, Wang RH, Wang H.
    Cardiovasc Res; 2009 Aug 01; 83(3):444-56. PubMed ID: 19304734
    [Abstract] [Full Text] [Related]

  • 4. Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablation.
    Nabokov A, Amann K, Wagner J, Gehlen F, Münter K, Ritz E.
    Nephrol Dial Transplant; 1996 Mar 01; 11(3):514-20. PubMed ID: 8671823
    [Abstract] [Full Text] [Related]

  • 5. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
    Nishida M, Hasegawa Y, Tanida I, Nakagawa E, Inaji H, Ohkita M, Matsumura Y.
    Eur J Pharmacol; 2009 Jul 01; 614(1-3):70-6. PubMed ID: 19379725
    [Abstract] [Full Text] [Related]

  • 6. Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.
    Thorin E, Pham-Dang M, Clement R, Mercier I, Calderone A.
    Br J Pharmacol; 2003 Dec 01; 140(7):1187-92. PubMed ID: 14597597
    [Abstract] [Full Text] [Related]

  • 7. Enhanced cardiac inflammation and fibrosis in ovariectomized hypertensive rats: a possible mechanism of diastolic dysfunction in postmenopausal women.
    Mori T, Kai H, Kajimoto H, Koga M, Kudo H, Takayama N, Yasuoka S, Anegawa T, Kai M, Imaizumi T.
    Hypertens Res; 2011 Apr 01; 34(4):496-502. PubMed ID: 21248760
    [Abstract] [Full Text] [Related]

  • 8. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H, Faulhaber J, Münter K, Kirchengast M, Wiesner RJ.
    Hypertension; 1999 Apr 01; 33(4):954-60. PubMed ID: 10205230
    [Abstract] [Full Text] [Related]

  • 9. Amlodipine decreases fibrosis and cardiac hypertrophy in spontaneously hypertensive rats: persistent effects after withdrawal.
    Sevilla MA, Voces F, Carrón R, Guerrero EI, Ardanaz N, San Román L, Arévalo MA, Montero MJ.
    Life Sci; 2004 Jul 02; 75(7):881-91. PubMed ID: 15183079
    [Abstract] [Full Text] [Related]

  • 10. Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage.
    Jesmin S, Zaedi S, Maeda S, Togashi H, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 02; 231(6):919-24. PubMed ID: 16741024
    [Abstract] [Full Text] [Related]

  • 11. The cardiac endothelin system in established pressure overload left ventricular hypertrophy.
    Schunkert H, Orzechowski HD, Böcker W, Meier R, Riegger GA, Paul M.
    J Mol Med (Berl); 1999 Aug 02; 77(8):623-30. PubMed ID: 10543394
    [Abstract] [Full Text] [Related]

  • 12. Characterization of an animal model of postmenopausal cardiac hypertrophy and novel mechanisms responsible for cardiac decompensation using ovariectomized pressure-overloaded rats.
    Bhuiyan MS, Fukunaga K.
    Menopause; 2010 Aug 02; 17(1):213-21. PubMed ID: 19741553
    [Abstract] [Full Text] [Related]

  • 13. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
    Park JB, Schiffrin EL.
    Hypertension; 2001 Jun 02; 37(6):1444-9. PubMed ID: 11408393
    [Abstract] [Full Text] [Related]

  • 14. Contribution of endothelin-1 to renal activator protein-1 activation and macrophage infiltration in aldosterone-induced hypertension.
    Tostes RC, Touyz RM, He G, Chen X, Schiffrin EL.
    Clin Sci (Lond); 2002 Aug 02; 103 Suppl 48():25S-30S. PubMed ID: 12193048
    [Abstract] [Full Text] [Related]

  • 15. Ovariectomy augments pressure overload-induced hypertrophy associated with changes in Akt and nitric oxide synthase signaling pathways in female rats.
    Bhuiyan MS, Shioda N, Fukunaga K.
    Am J Physiol Endocrinol Metab; 2007 Dec 02; 293(6):E1606-14. PubMed ID: 17878225
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of tamoxifen and angiotensin II type-1 receptor antagonist therapy on the hemodynamic profile of the ovariectomized female rat.
    Pham-Dang ML, Clement R, Mercier I, Calderone A.
    Can J Physiol Pharmacol; 2003 Sep 02; 81(9):915-9. PubMed ID: 14614530
    [Abstract] [Full Text] [Related]

  • 17. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
    Park JB, Schiffrin EL.
    Am J Hypertens; 2002 Feb 02; 15(2 Pt 1):164-9. PubMed ID: 11863252
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the transient outward K+ current by inhibition of endothelin-A receptors in normal and hypertrophied rat hearts.
    Wagner M, Goltz D, Stucke C, Schwoerer AP, Ehmke H, Volk T.
    Pflugers Arch; 2007 Jul 02; 454(4):595-604. PubMed ID: 17333248
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.
    Bird JE, Moreland S, Waldron TL, Powell JR.
    Hypertension; 1995 Jun 02; 25(6):1191-5. PubMed ID: 7768562
    [Abstract] [Full Text] [Related]

  • 20. Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice.
    Lund AK, Goens MB, Nuñez BA, Walker MK.
    Toxicol Appl Pharmacol; 2006 Apr 15; 212(2):127-35. PubMed ID: 16099489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.